These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 16824047)
1. Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice. Yavich L; Jäkälä P; Tanila H J Neurochem; 2006 Nov; 99(3):724-32. PubMed ID: 16824047 [TBL] [Abstract][Full Text] [Related]
2. Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein. Yavich L; Oksman M; Tanila H; Kerokoski P; Hiltunen M; van Groen T; Puoliväli J; Männistö PT; García-Horsman A; MacDonald E; Beyreuther K; Hartmann T; Jäkälä P Neurobiol Dis; 2005 Nov; 20(2):303-13. PubMed ID: 16242637 [TBL] [Abstract][Full Text] [Related]
3. Role of alpha-synuclein in synaptic glutamate release. Gureviciene I; Gurevicius K; Tanila H Neurobiol Dis; 2007 Oct; 28(1):83-9. PubMed ID: 17689254 [TBL] [Abstract][Full Text] [Related]
4. Perivascular nerve fiber α-synuclein regulates contractility of mouse aorta: a link to autonomic dysfunction in Parkinson's disease. Marrachelli VG; Miranda FJ; Alabadí JA; Milán M; Cano-Jaimez M; Kirstein M; Alborch E; Fariñas I; Pérez-Sánchez F Neurochem Int; 2010 Jul; 56(8):991-8. PubMed ID: 20420875 [TBL] [Abstract][Full Text] [Related]
5. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein. Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219 [TBL] [Abstract][Full Text] [Related]
6. Behavioural and neurochemical response of alpha-synuclein A30P transgenic mice to the effects of L-DOPA. Oksman M; Tanila H; Yavich L Neuropharmacology; 2009 Mar; 56(3):647-52. PubMed ID: 19084027 [TBL] [Abstract][Full Text] [Related]
7. Decreased reuptake of dopamine in the dorsal striatum in the absence of α-synuclein. Chadchankar H; Ihalainen J; Tanila H; Yavich L Brain Res; 2011 Mar; 1382():37-44. PubMed ID: 21276428 [TBL] [Abstract][Full Text] [Related]
8. Noradrenaline overflow in mouse dentate gyrus following locus coeruleus and natural stimulation: real-time monitoring by in vivo voltammetry. Yavich L; Jäkälä P; Tanila H J Neurochem; 2005 Nov; 95(3):641-50. PubMed ID: 16248883 [TBL] [Abstract][Full Text] [Related]
9. Motor impairment and aberrant production of neurochemicals in human alpha-synuclein A30P+A53T transgenic mice with alpha-synuclein pathology. Ikeda M; Kawarabayashi T; Harigaya Y; Sasaki A; Yamada S; Matsubara E; Murakami T; Tanaka Y; Kurata T; Wuhua X; Ueda K; Kuribara H; Ikarashi Y; Nakazato Y; Okamoto K; Abe K; Shoji M Brain Res; 2009 Jan; 1250():232-41. PubMed ID: 18992718 [TBL] [Abstract][Full Text] [Related]
10. The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain. Totterdell S; Hanger D; Meredith GE Brain Res; 2004 Apr; 1004(1-2):61-72. PubMed ID: 15033420 [TBL] [Abstract][Full Text] [Related]
11. Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice. Unger EL; Eve DJ; Perez XA; Reichenbach DK; Xu Y; Lee MK; Andrews AM Neurobiol Dis; 2006 Feb; 21(2):431-43. PubMed ID: 16230020 [TBL] [Abstract][Full Text] [Related]
12. Localization of alpha-synuclein to identified fibers and synapses in the normal mouse brain. Totterdell S; Meredith GE Neuroscience; 2005; 135(3):907-13. PubMed ID: 16112475 [TBL] [Abstract][Full Text] [Related]
13. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice. Schell H; Hasegawa T; Neumann M; Kahle PJ Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424 [TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour. George S; van den Buuse M; San Mok S; Masters CL; Li QX; Culvenor JG Exp Neurol; 2008 Apr; 210(2):788-92. PubMed ID: 18295208 [TBL] [Abstract][Full Text] [Related]
15. Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice. Wakamatsu M; Ishii A; Iwata S; Sakagami J; Ukai Y; Ono M; Kanbe D; Muramatsu S; Kobayashi K; Iwatsubo T; Yoshimoto M Neurobiol Aging; 2008 Apr; 29(4):574-85. PubMed ID: 17174013 [TBL] [Abstract][Full Text] [Related]
16. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice. Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925 [TBL] [Abstract][Full Text] [Related]
17. Subcellular localisation of recombinant alpha- and gamma-synuclein. Specht CG; Tigaret CM; Rast GF; Thalhammer A; Rudhard Y; Schoepfer R Mol Cell Neurosci; 2005 Feb; 28(2):326-34. PubMed ID: 15691713 [TBL] [Abstract][Full Text] [Related]
18. Role of alpha-synuclein in presynaptic dopamine recruitment. Yavich L; Tanila H; Vepsäläinen S; Jäkälä P J Neurosci; 2004 Dec; 24(49):11165-70. PubMed ID: 15590933 [TBL] [Abstract][Full Text] [Related]
19. Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Kontopoulos E; Parvin JD; Feany MB Hum Mol Genet; 2006 Oct; 15(20):3012-23. PubMed ID: 16959795 [TBL] [Abstract][Full Text] [Related]
20. Selective noradrenergic vulnerability in α-synuclein transgenic mice. Sotiriou E; Vassilatis DK; Vila M; Stefanis L Neurobiol Aging; 2010 Dec; 31(12):2103-14. PubMed ID: 19152986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]